PL3970730T3 - System for use and monitoring of inhaled nitric oxide with left ventricular assist devices - Google Patents

System for use and monitoring of inhaled nitric oxide with left ventricular assist devices

Info

Publication number
PL3970730T3
PL3970730T3 PL21206569.2T PL21206569T PL3970730T3 PL 3970730 T3 PL3970730 T3 PL 3970730T3 PL 21206569 T PL21206569 T PL 21206569T PL 3970730 T3 PL3970730 T3 PL 3970730T3
Authority
PL
Poland
Prior art keywords
monitoring
nitric oxide
left ventricular
ventricular assist
assist devices
Prior art date
Application number
PL21206569.2T
Other languages
Polish (pl)
Inventor
Jim POTENZIANO
Douglas Alan Greene
Craig Flanagan
Original Assignee
Mallinckrodt Pharmaceuticals Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharmaceuticals Ireland Limited filed Critical Mallinckrodt Pharmaceuticals Ireland Limited
Publication of PL3970730T3 publication Critical patent/PL3970730T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
    • A61M60/178—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring blood output from the heart, e.g. minute volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Clinical applications
    • A61B8/0883—Clinical applications for diagnosis of the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20—Type thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50—Details relating to control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50—Details relating to control
    • A61M60/508—Electronic control means, e.g. for feedback regulation
    • A61M60/515—Regulation using real-time patient data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/50—Details relating to control
    • A61M60/508—Electronic control means, e.g. for feedback regulation
    • A61M60/538—Regulation using real-time blood pump operational parameter data, e.g. motor current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/0816—Measuring devices for examining respiratory frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3303—Using a biosensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Mechanical Engineering (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL21206569.2T 2016-02-12 2017-01-30 System for use and monitoring of inhaled nitric oxide with left ventricular assist devices PL3970730T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662294711P 2016-02-12 2016-02-12

Publications (1)

Publication Number Publication Date
PL3970730T3 true PL3970730T3 (en) 2024-07-22

Family

ID=59559979

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21206569.2T PL3970730T3 (en) 2016-02-12 2017-01-30 System for use and monitoring of inhaled nitric oxide with left ventricular assist devices

Country Status (13)

Country Link
US (3) US11202899B2 (en)
EP (2) EP3970730B1 (en)
JP (2) JP2019513691A (en)
KR (2) KR20260007634A (en)
CN (2) CN119075171A (en)
AU (3) AU2017218391B2 (en)
CA (1) CA3012180C (en)
DK (1) DK3970730T3 (en)
ES (1) ES2981050T3 (en)
FI (1) FI3970730T3 (en)
PL (1) PL3970730T3 (en)
PT (1) PT3970730T (en)
WO (1) WO2017139113A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3379999B1 (en) 2015-11-24 2023-09-20 The Regents of the University of California Mapping and quantifying blood stasis and thrombus risk in the heart
BR112019004635A2 (en) * 2016-09-10 2019-06-18 Vero Biotech LLC portable nitric oxide release system and method
RU2020113418A (en) 2017-02-27 2020-10-05 Cёрд Поул, Инк. SYSTEMS AND METHODS FOR PRODUCING NITROGEN OXIDE UNDER AMBULATORY CONDITIONS
MX2020010523A (en) 2017-02-27 2021-02-09 Third Pole Inc Systems and methods for generating nitric oxide.
KR102354762B1 (en) 2017-02-27 2022-01-25 써드 폴, 아이엔씨. Nitric oxide generating system and method
WO2018183565A1 (en) 2017-03-29 2018-10-04 Harjes Daniel I Adjusting protocol based on irregular heart rhythm
US10835654B2 (en) 2017-03-29 2020-11-17 Tc1 Llc Pressure sensing ventricular assist devices and methods of use
US11065436B2 (en) 2017-03-29 2021-07-20 Tc1 Llc Communication methods and architecture for heart treatment systems
JP7414529B2 (en) 2017-06-07 2024-01-16 シファメド・ホールディングス・エルエルシー Intravascular fluid transfer devices, systems, and methods of use
JP2020532531A (en) * 2017-08-30 2020-11-12 ベレロフォン パルス テクノロジーズ エルエルシー Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with pulmonary disease
EP3703562A4 (en) * 2017-11-02 2022-04-06 Beyond Air, Inc. INHALATION OF NITROUS OXIDE
CN111556763B (en) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 Intravascular fluid movement device, system
KR20200127157A (en) * 2017-12-28 2020-11-10 벨레로폰 펄스 테크놀로지스 엘엘씨 Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension
EP3746149B1 (en) 2018-02-01 2025-08-06 Shifamed Holdings, LLC Intravascular blood pumps
EP3765113B1 (en) 2018-03-15 2024-10-30 Tc1 Llc Systems for preventing right heart failure
EP3768341A1 (en) 2018-03-19 2021-01-27 Tc1 Llc Coordinated ventricular assist and cardiac rhythm management devices and methods
WO2019195783A1 (en) * 2018-04-05 2019-10-10 The Regents Of The University Of California Mapping and quantifying shear stress and hemolysis in patients having lvads
US11241570B2 (en) 2018-07-17 2022-02-08 Tc1 Llc Systems and methods for inertial sensing for VAD diagnostics and closed loop control
WO2020028537A1 (en) 2018-07-31 2020-02-06 Shifamed Holdings, Llc Intravascaular blood pumps and methods of use
TW202021637A (en) * 2018-08-10 2020-06-16 美商貝勒羅豐治療公司 Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia
WO2020073047A1 (en) 2018-10-05 2020-04-09 Shifamed Holdings, Llc Intravascular blood pumps and methods of use
AU2020204681B2 (en) * 2019-01-04 2025-05-15 Mallinckrodt Pharmaceuticals Ireland Limited Use of inhaled nitric oxide (INO) for improving activity levels in patients with lung-related conditions
EP3969416A4 (en) 2019-05-15 2023-11-01 Third Pole, Inc. Systems and methods for generating nitric oxide
CN114269685A (en) 2019-05-15 2022-04-01 第三极股份有限公司 Electrode for nitric oxide generation
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US12465748B2 (en) 2019-08-07 2025-11-11 Supira Medical, Inc. Catheter blood pumps and collapsible pump housings
EP4501393A3 (en) 2019-09-25 2025-04-09 Shifamed Holdings, LLC Catheter blood pumps and collapsible pump housings
US12121713B2 (en) 2019-09-25 2024-10-22 Shifamed Holdings, Llc Catheter blood pumps and collapsible blood conduits
WO2021062265A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
WO2021109001A1 (en) * 2019-12-03 2021-06-10 深圳迈瑞生物医疗电子股份有限公司 Patient ventilation monitoring apparatus and ventilation monitoring method therefor
EP4072650A4 (en) 2019-12-11 2024-01-10 Shifamed Holdings, LLC DESCENDING AORTA AND VEINA CAVA BLOOD PUMPS
CN111135406B (en) * 2020-01-10 2023-08-08 宁波戴维医疗器械股份有限公司 High-frequency breathing machine
WO2021142472A1 (en) 2020-01-11 2021-07-15 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
US12307666B2 (en) * 2020-04-30 2025-05-20 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for predicting post-operative right ventricular failure using echocardiograms
US20210395905A1 (en) 2020-06-18 2021-12-23 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
US12509349B2 (en) 2020-10-16 2025-12-30 Third Pole, Inc. Nitric oxide generation process controls
CN116600844A (en) * 2020-11-17 2023-08-15 深圳迈瑞生物医疗电子股份有限公司 Respiratory support equipment, monitoring equipment, medical equipment system and parameter processing method
JP7598630B2 (en) * 2021-02-25 2024-12-12 株式会社サンメディカル技術研究所 Left ventricular assist artificial heart system and blood pump drive method
CN117279685A (en) * 2021-03-11 2023-12-22 第三极股份有限公司 System and method for generating and delivering nitric oxide
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide
USD1084344S1 (en) * 2021-10-13 2025-07-15 Vitalmex Internacional S.A. De C.V. Device for monitoring systolic, diastolic pressures and flow for use in a ventricular assist device
CN114098692B (en) * 2021-10-28 2022-09-30 北京心世纪医疗科技有限公司 Left ventricle auxiliary device implantation method based on blood flow distribution optimization
WO2023201363A2 (en) 2022-04-14 2023-10-19 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
ATE376850T1 (en) 1990-12-05 2007-11-15 Gen Hospital Corp DEVICE FOR TREATING PULMONARY VESSOR CONSTRUCTION AND ASTHMA
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
EP2724742B1 (en) 2004-08-18 2017-11-01 Geno LLC Conversion of nitrogen dioxide (no2) to nitric oxide (no)
EP1796655A2 (en) 2004-09-17 2007-06-20 Myogen, Inc. Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases
EP1885185A4 (en) 2005-05-09 2010-04-07 Mytogen Inc Cellular cardiomyoplasty as supportive therapy in patients with heart disease
CA2609456C (en) * 2005-05-25 2014-04-29 Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
WO2008067042A2 (en) * 2006-10-10 2008-06-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Modeling wound healing
CA3130908A1 (en) * 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
CA2819854A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
JP5923523B2 (en) 2011-01-06 2016-05-24 アイ・エヌ・オー セラピューティクス エル・エル・シーＩＮＯ Ｔｈｅｒａｐｅｕｔｉｃｓ ＬＬＣ Gas delivery device and system
WO2012166534A1 (en) * 2011-05-27 2012-12-06 Geno Llc Method of determining vasoreactivity using inhaled nitric oxide
CA2892398C (en) 2012-12-04 2023-02-14 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
US20140163397A1 (en) * 2012-12-07 2014-06-12 Shape Medical Systems, LLC Gas Exchange Testing and Auxiliary Gas Delivery Apparatus
CA2905994C (en) 2013-03-15 2022-01-04 Ino Therapeutics Llc Therapeutic gas delivery device with pulsed and continuous flow control
US9629358B2 (en) * 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids

Also Published As

Publication number Publication date
JP2019513691A (en) 2019-05-30
KR20260007634A (en) 2026-01-14
KR20190014493A (en) 2019-02-12
PT3970730T (en) 2024-07-30
WO2017139113A1 (en) 2017-08-17
AU2017218391A1 (en) 2018-07-26
EP3970730A1 (en) 2022-03-23
EP3413899A4 (en) 2019-10-02
CA3012180A1 (en) 2017-08-17
US20170232166A1 (en) 2017-08-17
JP7220269B2 (en) 2023-02-09
AU2017218391B2 (en) 2022-11-24
AU2023200638A1 (en) 2023-03-09
DK3970730T3 (en) 2024-05-27
JP2022008827A (en) 2022-01-14
FI3970730T3 (en) 2024-05-28
AU2025204154A1 (en) 2025-06-26
WO2017139113A9 (en) 2017-11-30
US20190046705A1 (en) 2019-02-14
CA3012180C (en) 2025-11-18
ES2981050T3 (en) 2024-10-07
US11759620B2 (en) 2023-09-19
US10398820B2 (en) 2019-09-03
CN108883126A (en) 2018-11-23
EP3413899A1 (en) 2018-12-19
US11202899B2 (en) 2021-12-21
US20210330957A1 (en) 2021-10-28
AU2023200638B2 (en) 2025-04-24
EP3970730B1 (en) 2024-05-01
CN119075171A (en) 2024-12-06
NZ744231A (en) 2025-07-25
CN108883126B (en) 2024-10-01
KR102905144B1 (en) 2025-12-31

Similar Documents

Publication Publication Date Title
PL3970730T3 (en) System for use and monitoring of inhaled nitric oxide with left ventricular assist devices
IL291718A (en) Oxygen reduction disposable kits, devices and methods of use thereof
ZA201901594B (en) Protection of electronics in negative pressure wound therapy systems
PT2967434T (en) Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide
IL275683A (en) Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension
EP3285849A4 (en) Steerable medical devices, systems, and methods of use
EP3274037A4 (en) Steerable medical devices, systems, and methods of use
IL265881A (en) Inhaler and methods of use thereof
EP3302277A4 (en) Nitric oxide treatment system and method
IL249143A0 (en) Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals
GB201516558D0 (en) An inhalable composition and an inhaler
EP3013407A4 (en) Medical treatment system and method of use
EP3077035A4 (en) Steerable medical devices, systems, and methods of use
EP3316875A4 (en) Methods to diagnose and treat acute respiratory infections
ZA201705633B (en) A new quinoline derivative for use in the treatment and prevention of viral infections
EP3116484A4 (en) Treating diseases using nitric oxide releasing solutions
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
EP2968309A4 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
CA3290134A1 (en) Nitric oxide inhalation therapy for infants with bronchiolitis
PL3285636T3 (en) Phoropter system and method of use
EP3116363A4 (en) Nitrous oxide mixtures and methods of use
ZA201801134B (en) Hydroxytriazine compound and medical use thereof
EP3363489A4 (en) Humidifier and respiratory assist device
EP3065674A4 (en) Monolithic medical devices and methods of use
EP3145573A4 (en) Portable medical treatment system and method of use